MEND
CompanyUnited States
MEND develops one asset, in phase 2 (MEND Repair & Recover in femoral fractures). Mostly supplement acting on proteostasis; based in the United States.
- 1
- Asset
- Furthest stage
- Phase 2
- 0
- Trials
- 1
- Signal
Pipeline
1Essential amino acid-based nutritional supplement supporting skeletal muscle protein synthesis.
Phase 2, Supplement, Proteostasis, femoral fractures, fragility fracture
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials1
- Signals1
- Similar companies6